113 related articles for article (PubMed ID: 37831605)
1. Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.
Chen S; Wu Y; Gao Y; Wu C; Wang Y; Hou C; Ren M; Zhang S; Zhu Q; Zhang J; Yao Y; Huang M; Qi YB; Liu XS; Horng T; Wang H; Ye D; Zhu Z; Zhao S; Fan G
Cell Rep; 2023 Oct; 42(10):113246. PubMed ID: 37831605
[TBL] [Abstract][Full Text] [Related]
2. A functional loop between YTH domain family protein YTHDF3 mediated m
Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
[TBL] [Abstract][Full Text] [Related]
3. Site-specific crosslinking reveals Phosphofructokinase-L inhibition drives self-assembly and attenuation of protein interactions.
Sivadas A; McDonald EF; Shuster SO; Davis CM; Plate L
Adv Biol Regul; 2023 Dec; 90():100987. PubMed ID: 37806136
[TBL] [Abstract][Full Text] [Related]
4. miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.
Li N; Wang X; Sun J; Liu Y; Han A; Lin Z; Yang Y
Carcinogenesis; 2022 Aug; 43(7):705-715. PubMed ID: 35511493
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway.
Zhang X; Yan K; Deng L; Liang J; Liang H; Feng D; Ling B
Cell Transplant; 2019 Dec; 28(1_suppl):1S-13S. PubMed ID: 31822119
[TBL] [Abstract][Full Text] [Related]
6. Altered brain glucose metabolism in transgenic-PFKL mice with elevated L-phosphofructokinase: in vivo NMR studies.
Peled-Kamar M; Degani H; Bendel P; Margalit R; Groner Y
Brain Res; 1998 Nov; 810(1-2):138-45. PubMed ID: 9813288
[TBL] [Abstract][Full Text] [Related]
7.
Zheng J; Luo J; Zeng H; Guo L; Shao G
Biomed Pharmacother; 2019 Nov; 119():109402. PubMed ID: 31514072
[TBL] [Abstract][Full Text] [Related]
8. PTGES3 is a Putative Prognostic Marker in Breast Cancer.
Adekeye A; Agarwal D; Nayak A; Tchou J
J Surg Res; 2022 Mar; 271():154-162. PubMed ID: 34920330
[TBL] [Abstract][Full Text] [Related]
9. COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion.
Qiu X; Cheng JC; Chang HM; Leung PC
Endocr Relat Cancer; 2014 Aug; 21(4):533-43. PubMed ID: 24969217
[TBL] [Abstract][Full Text] [Related]
10. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
[TBL] [Abstract][Full Text] [Related]
11. Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner.
Zheng C; Yu X; Liang Y; Zhu Y; He Y; Liao L; Wang D; Yang Y; Yin X; Li A; He Q; Li B
Acta Pharm Sin B; 2022 Mar; 12(3):1271-1287. PubMed ID: 35530161
[TBL] [Abstract][Full Text] [Related]
12. Gene dosage and Down's syndrome: metabolic and enzymatic changes in PC12 cells overexpressing transfected human liver-type phosphofructokinase.
Elson A; Bernstein Y; Degani H; Levanon D; Ben-Hur H; Groner Y
Somat Cell Mol Genet; 1992 Mar; 18(2):143-61. PubMed ID: 1533471
[TBL] [Abstract][Full Text] [Related]
13. PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer.
Yang J; Li J; Le Y; Zhou C; Zhang S; Gong Z
Am J Cancer Res; 2016; 6(2):473-85. PubMed ID: 27186417
[TBL] [Abstract][Full Text] [Related]
14. TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation.
Li L; Li L; Li W; Chen T; Bin Zou ; Zhao L; Wang H; Wang X; Xu L; Liu X; Wang D; Li B; Mak TW; Du W; Yang X; Jiang P
Nat Commun; 2018 Nov; 9(1):4683. PubMed ID: 30409970
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Zhang D; Wang Y; Dong L; Huang Y; Yuan J; Ben W; Yang Y; Ning N; Lu M; Guan Y
Cancer Sci; 2013 Dec; 104(12):1690-6. PubMed ID: 24112101
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion.
Spinella F; Rosanò L; Di Castro V; Natali PG; Bagnato A
J Biol Chem; 2004 Nov; 279(45):46700-5. PubMed ID: 15347673
[TBL] [Abstract][Full Text] [Related]
17. Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness.
Fujita M; Imadome K; Somasundaram V; Kawanishi M; Karasawa K; Wink DA
BMC Cancer; 2020 Sep; 20(1):929. PubMed ID: 32993545
[TBL] [Abstract][Full Text] [Related]
18. Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis.
Nagaraja AS; Dorniak PL; Sadaoui NC; Kang Y; Lin T; Armaiz-Pena G; Wu SY; Rupaimoole R; Allen JK; Gharpure KM; Pradeep S; Zand B; Previs RA; Hansen JM; Ivan C; Rodriguez-Aguayo C; Yang P; Lopez-Berestein G; Lutgendorf SK; Cole SW; Sood AK
Oncogene; 2016 May; 35(18):2390-7. PubMed ID: 26257064
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose-induced insulin response in transgenic mice overexpressing the L-phosphofructokinase gene.
Knobler H; Weiss Y; Peled M; Groner Y
Diabetes; 1997 Sep; 46(9):1414-8. PubMed ID: 9287040
[TBL] [Abstract][Full Text] [Related]
20. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
